Abstract, Snapshot, Market Analysis & Market Definition: Diabetic Foot Ulcer (DFU) Treatment Market
Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Diabetic foot ulcers are among one of the major global medical issues. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation. Key players operating in the global Diabetic Foot Ulcer (DFU) Treatment market are 3M, Smith & Nephew, Molnlycke Health Care, ConvaTec, etc. Top 4 companies occupied about 35% market. The classification of Diabetic Foot Ulcer (DFU) Treatment includes Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Others, and the proportion of Biologics in 2018 is about 40.1%. Diabetic Foot Ulcer (DFU) Treatment is widely used to treat Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. The most proportion of Diabetic Foot Ulcer (DFU) Treatment is Neuropathic Ulcers and the proportion in 2018 is 54.1%. North America is the largest consumption place, with a consumption market share nearly 51.2% in 2018. In 2018, the global Diabetic Foot Ulcer (DFU) Treatment market size was 3775 million US$ and it is expected to reach 6073 million US$ by the end of 2025, with a CAGR of 0.068 during 2019-2025. This report focuses on the global Diabetic Foot Ulcer (DFU) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Foot Ulcer (DFU) Treatment development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Diabetic Foot Ulcer (DFU) Treatment Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic MedicationThe proportion of Biologics in 2018 is about 40.1%, which is the biggest segment.
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic UlcersDiabetic Foot Ulcer (DFU) Treatment is widely used to treat Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. The most proportion of Diabetic Foot Ulcer (DFU) Treatment is Neuropathic Ulcers and the proportion in 2018 is 54.1%.
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Diabetic Foot Ulcer (DFU) Treatment Market
3M
Smith & Nephew
Molnlycke Health Care
ConvaTec
Coloplast
Integra LifeSciences
Essity (BSN Medical)
Medline
B. Braun
Organogenesis
Key Insights Covered: Exhaustive Diabetic Foot Ulcer (DFU) Treatment Market
1. Market size (sales, revenue and growth rate) of Diabetic Foot Ulcer (DFU) Treatment industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Diabetic Foot Ulcer (DFU) Treatment industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Diabetic Foot Ulcer (DFU) Treatment industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Diabetic Foot Ulcer (DFU) Treatment industry.
Research Methodology: Diabetic Foot Ulcer (DFU) Treatment Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.